Viewing Study NCT02842112


Ignite Creation Date: 2025-12-26 @ 10:43 PM
Ignite Modification Date: 2026-02-17 @ 8:15 PM
Study NCT ID: NCT02842112
Status: COMPLETED
Last Update Posted: 2016-07-25
First Post: 2016-07-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Higher Percentage of CD34+ CD38- Cells Detected by Multiparameter Flow Cytometry From Leukapheresis Products Predicts Unsustained Complete Remission in Acute Myeloid Leukemia
Sponsor:
Organization:

Study Design

Study Type: OBSERVATIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: False
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count:
Enrollment Type:
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Time Perspective List:
Who Masked List: